Dec 29, 2025 • WANE 15
BEARISH
TEMPUS AI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - T
Kahn Swick & Foti, LLC (KSF) is reminding investors of Tempus AI, Inc. (NasdaqGS: TEM) who suffered losses exceeding $100,000 of the lead plaintiff deadline on August 12, 2025, in a securities class action lawsuit. The lawsuit alleges that Tempus AI and its executives failed to disclose material information during the Class Period, specifically regarding overstated AI capabilities, aggressive accounting, and issues with management and past financial reporting. Investors who purchased shares between August 6, 2024, and May 27, 2025, are affected.
Dec 20, 2025 • FOX40 News
BEARISH
TEM Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Tempus AI, Inc. Class Action
Robbins LLP reminds investors of the lead plaintiff deadline in the class action lawsuit against Tempus AI, Inc. The lawsuit alleges that Tempus AI inflated the value of contract agreements, misrepresented its AI capabilities, and engaged in aggressive billing practices. These issues led to a significant drop in Tempus common stock after a report by Spruce Point Capital Management, LLC.
Dec 16, 2025 • The Globe and Mail
NEUTRAL
Bank of America Securities Sticks to Their Hold Rating for Tempus AI, Inc. Class A (TEM)
Bank of America Securities reiterated a Hold rating on Tempus AI, Inc. Class A (NASDAQ: TEM) with a price target of $80.00. This follows similar ratings from other firms, while Morgan Stanley maintained a Buy rating. The company reported increased revenue but also an increased GAAP net loss in its latest quarter, and corporate insider sentiment is negative due to increased selling activity.
Dec 16, 2025 • Yahoo Finance
SOMEWHAT-BEARISH
Tempus AI price target lowered to $80 from $90 at BofA
BofA analyst Michael Ryskin has lowered the price target for Tempus AI (TEM) to $80 from $90, while maintaining a Neutral rating. The adjustment is part of a firm-wide update for Life Sciences & Diagnostic Tools stocks, anticipating a market normalization and a return to spending by Biopharma in 2026. BofA favors companies with higher exposure to research and development.
Dec 15, 2025 • TipRanks
BEARISH
Tempus AI price target lowered to $80 from $85 at JPMorgan
JPMorgan analyst Casey Woodring has lowered the price target for Tempus AI (TEM) to $80 from $85 while maintaining a Neutral rating on the shares. This adjustment reflects updated models within the life science tools and diagnostics sector.
Dec 13, 2025 • TradingView — Track All Markets
BEARISH
Tempus AI CFO Rogers James William Sells Shares
Tempus AI CFO and 10% Owner, Rogers James William, sold 19,966 shares of Class A Common Stock on December 11, 2025, for a total of $1,461,479. The sale was executed under a Rule 10b5-1 trading plan at weighted average prices between $72.09 and $74.08. Following this transaction, Rogers James William directly owns 111,250 shares in Tempus AI.